drugset / Trial / NCT03935594

Use of Autologous Platelet-Rich Plasma to Treat Hypertrophic Burn Scars

NCT03935594

Phase 2 Terminated 3 enrolled Vanderbilt University Medical Center
RandomizedParallel-groupSingle-blindTreatment

Summary

Hypertrophic burn scars are experienced by more than 70% of burn victims. They are a major source of decreased quality of life in burn patients due to pain, decreased range of motion, and poor cosmetic appearance. Current treatment strategies (including fat grafting and laser resurfacing) are either highly invasive, prohibitively costly, or painful. Autologous Platelet Rich Plasma (PRP) does not require anesthesia, and is an inexpensive, safe, fast, and less painful alternative that has been recognized for its role in reducing scars associated with acne, among other things. While PRP has not been studied specifically in burn scars, there is sufficient theoretical and practical evidence that it will improve the appearance and feel of these debilitating scars, representing a large potential benefit for these patients with minimal associated risk.

Timeline

Start
2020-09-18
Primary completion
2021-05-24
Completion
2022-10-19

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified 1 ml Other

Indications

No indication recorded.